{"product_id":"male-lower-urinary-tract-symptoms-and-benign-prostatic-hyperplasia-isbn-9781118437995","title":"Male Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia","description":"\u003cp\u003e\u003ci\u003eMale Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia\u003c\/i\u003e provides urologists of all levels with a practical, highly clinical guide to the variety of different symptoms and problems concerning the male lower urinary tract, including benign prostatic hyperplasia, one of the conditions that urologists most regularly encounter.  \u003c\/p\u003e \u003cp\u003eEvidence-based throughout and written by the world's leading experts in the topic, it comprehensively reviews the very latest in diagnostics and imaging, patient phenotyping, genetic studies, medical and surgical therapies, and lifestyle management in order to help clinicians best manage their patients.\u003cbr\u003e\u003cbr\u003eHighlights include chapters on: \u003c\/p\u003e \u003cul\u003e \u003cli\u003eAlpha-Adrenergic Antagonists for Lower Urinary Symptoms Secondary to Benign Prostatic Hyperplasia\u003c\/li\u003e \u003cli\u003ePhosphodiesterase Type 5 inhibitors for Male LUTS\u003c\/li\u003e \u003cli\u003eCombination Medical Therapy for Male LUTS\u003c\/li\u003e \u003cli\u003eOpen Simple Prostatectomy\u003c\/li\u003e \u003cli\u003eMinimally Invasive Therapies\u003c\/li\u003e \u003cli\u003eMonopolar and Bipolar Transurethral Resection of the Prostate\u003c\/li\u003e \u003cli\u003eGreenLight Laser Therapy\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eContaining pitfall boxes and key points throughout to aid quick and easy understanding of the key information, this excellent book is an essential read for the modern-day urologist.\u003c\/p\u003e  \u003cp\u003eContributors, vii\u003c\/p\u003e \u003cp\u003e1 Etiology and Pathogenesis, 1\u003cbr\u003e \u003ci\u003eRobert H. Getzenberg \u0026amp; Prakash Kulkarni\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: Epidemiology, Correlates, and Risk Factors, 10\u003cbr\u003e \u003ci\u003eRaymond C. Rosen \u0026amp; Benjamin N. Breyer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Clinical Assessment and Diagnosis of Lower Urinary Tract Dysfunction: United States, 22\u003cbr\u003e \u003ci\u003eChristopher P. Filson \u0026amp; John T. Wei\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 Clinical Assessment and Diagnosis of Lower Urinary Tract Symptoms\/Benign Prostatic Hyperplasia: Europe, 37\u003cbr\u003e \u003ci\u003eStavros Gravas \u0026amp; Jean J. M. C. H. de la Rosette\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Clinical Assessment and Diagnosis of Lower Urinary Tract Symptoms\/Benign Prostatic Hyperplasia: Primary Care, 47\u003cbr\u003e \u003ci\u003eMatt T. Rosenberg, John B. Riley \u0026amp; Marty M. Miner\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 Watchful Waiting, 59\u003cbr\u003e \u003ci\u003eReginald Bruskewitz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 α-Adrenergic Antagonists for Lower Urinary Symptoms Secondary to Benign Prostatic Hyperplasia, 70\u003cbr\u003e \u003ci\u003eNathaly François, Raunak D. Patel \u0026amp; Kevin T. McVary\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 5α-Reductase Inhibitors, 90\u003cbr\u003e \u003ci\u003eClaudius Füllhase \u0026amp; Roberto Soler\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Antimuscarinics, 100\u003cbr\u003e \u003ci\u003eNadir I. Osman \u0026amp; Christopher R. Chapple\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 The Use of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia, 113\u003cbr\u003e \u003ci\u003eCasey Lythgoe \u0026amp; Kevin T. McVary\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Combination Medical Therapy for Male Lower Urinary Tract Symptoms, 129\u003cbr\u003e \u003ci\u003eClaus G. Roehrborn\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Complementary Therapy, 154\u003cbr\u003e \u003ci\u003eAaron E. Katz \u0026amp; Anne Darves-Bornoz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Open Simple Prostatectomy, 164\u003cbr\u003e \u003ci\u003eAnnika Herlemann, Matthias Oelke \u0026amp; Christian Gratzke\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 Minimally Invasive Therapies, 175\u003cbr\u003e \u003ci\u003eMauro Gacci, Matteo Salvi and Arcangelo Sebastianelli\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Holmium Laser Prostatectomy, 184\u003cbr\u003e \u003ci\u003eSimon van Rij \u0026amp; Peter J. Gilling\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 Benign Prostatic Hyperplasia: GreenLight Laser Therapy, 191\u003cbr\u003e \u003ci\u003eAlexis E. Te \u0026amp; Bilal Chughtai\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 Principles of Electrocautery-Based Techniques, 201\u003cbr\u003e \u003ci\u003eAaron M. Bernie \u0026amp; Richard Lee\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex, 211\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSteven A. Kaplan, MD, E. Darracott Vaughan Jr. Professor of Urology, Director, Iris Cantor Men's Health Center, New York Presbyterian Hospital, New York, NY, USA\u003c\/b\u003e\u003cbr\u003eDr. Kaplan has had over 725 articles and 170 abstracts published and has made over 300 presentations in more than 35 countries. He is the author of two books and is on the Editorial Board of \u003ci\u003eUrology\u003c\/i\u003e, \u003ci\u003eJournal of Urology\u003c\/i\u003e, \u003ci\u003eWiley's BJUI\u003c\/i\u003e and \u003ci\u003eUrology Times\u003c\/i\u003e. A member of more than 30 professional organizations, he is also a member of the WHO Committee on treating BPH, has been awarded 5 NIH grants and has received over 13 million dollars in research funding. He was awarded the John K. Lattimer Award for Lifetime Achievement in Urology by the National Kidney Foundation.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eKevin T. McVary, MD, FACS, Professor and Chair, Division of Urology, Southern Illinois University School of Medicine, Springfield, IL, USA\u003c\/b\u003e\u003cbr\u003eDr. McVary is Chairman of both the AUA BPH Clinical Guidelines Committee and the Special Emphasis Urology Study Section for the NIDDK. He is Co-Chairman of the Clinical Section of the NIDDK Strategic Pathway for Prostate Basic and Clinical Science, and the AUA Honorary Speaker at the European Association of Urology (EAU). Dr. McVary has been principal investigator for more than 75 clinical trials and his research has generated more than 120 publications including journal articles, book chapters, and abstracts. His work has appeared in prominent journals such as the \u003ci\u003eJournal of Urology\u003c\/i\u003e, \u003ci\u003eJournal of the American Medical Association (JAMA)\u003c\/i\u003e, \u003ci\u003eNew England Journal of Medicine\u003c\/i\u003e, \u003ci\u003eInternational Journal of Impotence Research\u003c\/i\u003e, and \u003ci\u003eUrology\u003c\/i\u003e. He is an editorial consultant for the \u003ci\u003eJournal of Andrology\u003c\/i\u003e, \u003ci\u003eJournal of Urology\u003c\/i\u003e, \u003ci\u003eUrology\u003c\/i\u003e, \u003ci\u003eJournal of Investigative Urology\u003c\/i\u003e, \u003ci\u003eCurrent Opinion in Urology\u003c\/i\u003e, and \u003ci\u003eProstate Diseases\u003c\/i\u003e.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eMale Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia\u003c\/i\u003e provides urologists of all levels with a practical, highly clinical guide to the variety of different symptoms and problems concerning the male lower urinary tract, including benign prostatic hyperplasia, one of the conditions that urologists most regularly encounter.\u003c\/p\u003e \u003cp\u003eEvidence-based throughout and written by the world's leading experts in the topic, it comprehensively reviews the very latest in diagnostics and imaging, patient phenotyping, genetic studies, medical and surgical therapies, and lifestyle management in order to help clinicians best manage their patients.\u003c\/p\u003e \u003cp\u003eHighlights include chapters on:\u003c\/p\u003e \u003cul\u003e \u003cli\u003eAlpha-Adrenergic Antagonists for Lower Urinary Symptoms Secondary to Benign Prostatic Hyperplasia\u003c\/li\u003e \u003cli\u003ePhosphodiesterase Type 5 inhibitors for Male LUTS\u003c\/li\u003e \u003cli\u003eCombination Medical Therapy for Male LUTS\u003c\/li\u003e \u003cli\u003eOpen Simple Prostatectomy\u003c\/li\u003e \u003cli\u003eMinimally Invasive Therapies\u003c\/li\u003e \u003cli\u003eMonopolar and Bipolar Transurethral Resection of the Prostate\u003c\/li\u003e \u003cli\u003eGreenLight Laser Therapy\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eContaining pitfall boxes and key points throughout to aid quick and easy understanding of the key information, this excellent book is an essential read for the modern-day urologist.\u003c\/p\u003e \u003cp\u003eTitles of Related Interest\u003c\/p\u003e \u003cp\u003e\u003ci\u003eTop Tips in Urology\u003c\/i\u003e\u003cbr\u003eMcLoughlin, ISBN 978-0-470-67293-8\u003c\/p\u003e \u003cp\u003e\u003ci\u003eProstate Cancer: Diagnosis and Clinical Management\u003c\/i\u003e\u003cbr\u003eTewari, ISBN 978-1-118-34735-5\u003c\/p\u003e \u003cp\u003e\u003cb\u003eWebsite\u003c\/b\u003e, www.wiley.com\/go\/urology\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989558214885,"sku":"NP9781118437995","price":110.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781118437995.jpg?v=1761784589","url":"https:\/\/k12savings.com\/es\/products\/male-lower-urinary-tract-symptoms-and-benign-prostatic-hyperplasia-isbn-9781118437995","provider":"K12savings","version":"1.0","type":"link"}